皮肤科环境下银屑病关节炎患者管理共识
BACKGROUND: Psoriatic arthritis (PsA) is a chronic inflammatory disease associated with psoriasis (PsO). Early diagnosis and prompt therapeutic intervention are crucial for limiting PsA progression and prevention of disability.…
要点
- 皮肤科医生应识别炎症性与非炎症性关节症状以早期发现PsA。
- 共识推荐了筛查问卷、血清学检查和影像学技术用于早期检测。
- 明确皮肤科转诊风湿科的指征及PsA诊断标准和活动度评估指标。
核心结论
- 实施这些实用推荐有助于皮肤科环境下银屑病关节炎的早期诊断和治疗管理。
研究设计与样本
- 采用面对面会议和名义组技术,通过德尔菲法达成100%共识。
主要发现
- 共识定义了区分炎症性与非炎症性关节症状的临床特征。
- 共识确定了临床实践中最有价值的PsA鉴别诊断、筛查问卷、血清学检查和影像学技术。
- 共识明确了皮肤科医生转诊银屑病患者至风湿科医生的标准以及PsA的诊断标准。
- 共识选择了皮肤科医生可用于评估PsA活动度和严重程度的指标。
- 共识报告了可用于治疗PsA的合成和生物改善病情抗风湿药。
关键数值与推荐
- 共识达成定义为100%同意。
- 专家组包括12名皮肤科医生和6名风湿科医生。
临床怎么用
- 皮肤科医生应使用共识推荐的筛查问卷、实验室检查和影像学技术早期检测PsA。
- 根据共识标准判断转诊风湿科医生的时机。
- 使用共识推荐的指标评估PsA活动度和严重程度,并参考系统治疗选择。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Psoriatic arthritis (PsA) is a chronic inflammatory disease associated with psoriasis (PsO). Early diagnosis and prompt therapeutic intervention are crucial for limiting PsA progression and prevention of disability. Dermatologists are in a privileged position to detect early PsA. The management of patients with PsA in the dermatology setting is widely variable. OBJECTIVE: To provide practical recommendations for the management of patients with PsA in the dermatology setting including early diagnosis and treatment. METHODS: A consensus document was written by an expert panel composed by dermatologists (n = 12) and rheumatologists (n = 6). Eleven highly relevant questions were selected and elaborated with answers/statements based on a narrative literature review. The resulting document was discussed in a face-to-face meeting adopting a nominal group technique to reach consensus (i.e. 100% agreement) using the Delphi method. RESULTS: A consensus was achieved in defining the following: the clinical characteristics differentiating inflammatory and non-inflammatory signs and symptoms of joint disease; the most important differential diagnoses of PsA in clinical practice; the most useful screening questionnaires, serum laboratory tests and imaging techniques for the detection of early PsA; the criteria for dermatologist to refer patients with PsO to rheumatologist; the criteria for the diagnosis of PsA; the selection of the indices that the dermatologist could use for measuring the activity and severity of PsA in clinical practice; when systemic steroids and/or intra-articular steroid injections are indicated in the treatment of PsA. Finally, systemic treatments including synthetic and biologic disease-modifying antirheumatic drugs to be considered for the treatment of PsA have been reported. CONCLUSIONS: The implementations of these practical recommendations could be very helpful for the management of patients with PsA in the dermatology setting including early diagnosis and treatment.
引用
- Gisondi P, Altomare G, Ayala F, et al. Consensus on the management of patients with psoriatic arthritis in a dermatology setting. J Eur Acad Dermatol Venereol. 2018. PMID: 29220551. doi:10.1111/jdv.14741
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。